Successful treatment of reboxetine-induced
urinary hesitancy with tamsulosin
by
Kasper S, Wolf R.
Department of General Psychiatry,
University of Vienna,
Hospital for Psychiatry,
Wahringer Gurtel 18--20, A-1090, Vienna, Austria
Eur Neuropsychopharmacol 2002 Apr;12(2):119-22

ABSTRACT

Urinary hesitancy can be an uncomfortable side effect during antidepressant treatment. Clinicians often use the selective alpha(1A)-adrenoceptor antagonist, tamsulosin, to treat urinary hesitancy associated with prostate enlargement. We report here a series of case studies in which tamsulosin has been successfully used in the management of urinary hesitancy during therapy with the selective noradrenaline reuptake inhibitor reboxetine for major depressive disorder (MDD). Eight male adults (aged 43--64 years; DSM-IV diagnosis of MDD) who were receiving treatment with reboxetine (4--8 mg/day) were considered candidates for concomitant tamsulosin (0.4 mg/day) therapy. Tamsulosin was administered either as prophylaxis (n=4) or as treatment (n=4) for emergent urinary hesitancy. All patients experienced relief of urinary hesitancy within 20 min of tamsulosin therapy and this effect was sustained. Concomitant treatment with tamsulosin should be considered for those patients in whom urinary hesitancy may lead to withdrawal from reboxetine therapy.

Efficacy
Reboxetine
Tamsulosin
Noradrenaline
NARIs and SSRIs
Urinary hesitancy
Reboxetine: structure
Reboxetine and the rat
Reboxetine and the elderly
Reboxetine versus fluoxetine
Reboxetine and major depression
Reboxetine and social functioning
Sexual function on reboxetine v paroxetine
Depression, antidepressants and noradrenaline


Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family